| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of calf muscle metabolism alterations in active cystic fibrosis adults with mild to moderate lung disease
|
Decorte, N.
|
|
2017
|
16 |
1 |
p. 98-106
9 p.
|
artikel
|
| 2 |
Acknowledgment to reviewers 2016
|
|
|
2017
|
16 |
1 |
p. 1-5
5 p.
|
artikel
|
| 3 |
Adherence to infection prevention and control guidelines: A vignette-based study of decision-making and risk-taking in young adults with cystic fibrosis
|
Bowmer, Grace
|
|
2017
|
16 |
1 |
p. 146-150
5 p.
|
artikel
|
| 4 |
Airway inflammation in mild cystic fibrosis
|
Eckrich, Jonas
|
|
2017
|
16 |
1 |
p. 107-115
9 p.
|
artikel
|
| 5 |
A simplified, semi-quantitative structural lung disease computed tomography outcome during quiet breathing in infants with cystic fibrosis
|
Saguintaah, Magali
|
|
2017
|
16 |
1 |
p. 151-157
7 p.
|
artikel
|
| 6 |
Bacterial proteases and haemostasis dysregulation in the CF lung
|
Reihill, James A.
|
|
2017
|
16 |
1 |
p. 49-57
9 p.
|
artikel
|
| 7 |
Biological variability of the sweat chloride in diagnostic sweat tests: A retrospective analysis
|
Vermeulen, F.
|
|
2017
|
16 |
1 |
p. 30-35
6 p.
|
artikel
|
| 8 |
BMI fails to identify poor nutritional status in stunted children with CF
|
Konstan, Michael W.
|
|
2017
|
16 |
1 |
p. 158-160
3 p.
|
artikel
|
| 9 |
Cancer risk among lung transplant recipients with cystic fibrosis
|
Fink, Aliza K.
|
|
2017
|
16 |
1 |
p. 91-97
7 p.
|
artikel
|
| 10 |
CFTR nonsense mutations: Therapeutic benefits from clinically approved drugs?
|
Foskett, J. Kevin
|
|
2017
|
16 |
1 |
p. 9-10
2 p.
|
artikel
|
| 11 |
Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor
|
Mesbahi, Myriam
|
|
2017
|
16 |
1 |
p. 45-48
4 p.
|
artikel
|
| 12 |
Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor
|
Fidler, Meredith C.
|
|
2017
|
16 |
1 |
p. 41-44
4 p.
|
artikel
|
| 13 |
Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapy
|
Elborn, J. Stuart
|
|
2017
|
16 |
1 |
p. 163-164
2 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2017
|
16 |
1 |
p. ii-
1 p.
|
artikel
|
| 15 |
Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation
|
Zeybel, Gemma L.
|
|
2017
|
16 |
1 |
p. 124-131
8 p.
|
artikel
|
| 16 |
Limitations to providing adult cystic fibrosis care in Europe: Results of a care centre survey
|
Madge, Susan
|
|
2017
|
16 |
1 |
p. 85-88
4 p.
|
artikel
|
| 17 |
Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients
|
Wettlaufer, Jillian
|
|
2017
|
16 |
1 |
p. 58-63
6 p.
|
artikel
|
| 18 |
News
|
|
|
2017
|
16 |
1 |
p. 11-12
2 p.
|
artikel
|
| 19 |
[No title]
|
Bell, Scott C.
|
|
2017
|
16 |
1 |
p. 6-
1 p.
|
artikel
|
| 20 |
Objective airway artery dimensions compared to CT scoring methods assessing structural cystic fibrosis lung disease
|
Kuo, Wieying
|
|
2017
|
16 |
1 |
p. 116-123
8 p.
|
artikel
|
| 21 |
Prevalence of elevated liver enzymes in children with cystic fibrosis diagnosed by newborn screen
|
Woodruff, Samantha A.
|
|
2017
|
16 |
1 |
p. 139-145
7 p.
|
artikel
|
| 22 |
Reduced survival in adult cystic fibrosis despite attenuated lung function decline
|
Keating, Claire
|
|
2017
|
16 |
1 |
p. 78-84
7 p.
|
artikel
|
| 23 |
Stroke and myocardial infarction following bronchial artery embolization in a cystic fibrosis patient
|
Hoffman, Matt
|
|
2017
|
16 |
1 |
p. 161-162
2 p.
|
artikel
|
| 24 |
The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis
|
Ramsay, Kay A.
|
|
2017
|
16 |
1 |
p. 70-77
8 p.
|
artikel
|
| 25 |
The effects of ivacaftor on CF fatty acid metabolism: An analysis from the GOAL study
|
O'Connor, Michael Glenn
|
|
2017
|
16 |
1 |
p. 132-138
7 p.
|
artikel
|
| 26 |
The fate of inhaled antibiotics after deposition in cystic fibrosis: How to get drug to the bug?
|
Bos, Aukje C.
|
|
2017
|
16 |
1 |
p. 13-23
11 p.
|
artikel
|
| 27 |
Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation
|
Mutyam, Venkateshwar
|
|
2017
|
16 |
1 |
p. 24-29
6 p.
|
artikel
|
| 28 |
Therapeutic benefit of ivacaftor in late cystic fibrosis caused by homozygous IVS8-5T CFTR polymorphism
|
Magne, F.
|
|
2017
|
16 |
1 |
p. 89-90
2 p.
|
artikel
|
| 29 |
Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy
|
Prigitano, Anna
|
|
2017
|
16 |
1 |
p. 64-69
6 p.
|
artikel
|
| 30 |
Variability of sweat chloride — A never ending story
|
Tümmler, Burkhard
|
|
2017
|
16 |
1 |
p. 7-8
2 p.
|
artikel
|
| 31 |
Variability of sweat chloride concentration in subjects with cystic fibrosis and G551D mutations
|
Vermeulen, F.
|
|
2017
|
16 |
1 |
p. 36-40
5 p.
|
artikel
|
Tijdschrift beschrijving